Pages that link to "Item:Q1754311"
From MaRDI portal
The following pages link to Literature review: the vaccine supply chain (Q1754311):
Displaying 17 items.
- The benefits of combining early aspecific vaccination with later specific vaccination (Q724146) (← links)
- Influenza vaccine supply chain coordination under uncertain supply and demand (Q2060405) (← links)
- Dynamic planning of a two-dose vaccination campaign with uncertain supplies (Q2079443) (← links)
- Resource distribution under spatiotemporal uncertainty of disease spread: stochastic versus robust approaches (Q2108123) (← links)
- Design of control strategies to help prevent the spread of COVID-19 pandemic (Q2171561) (← links)
- Strategies for ensuring required service level for COVID-19 herd immunity in Indian vaccine supply chain (Q2171581) (← links)
- Cold chain transportation decision in the vaccine supply chain (Q2286929) (← links)
- Optimal influenza vaccine distribution with equity (Q2286989) (← links)
- Complexity analysis of cold chain transportation in a vaccine supply chain considering activity inspection and time-delay (Q2668877) (← links)
- The impact of tariff policies on vaccine supply chains: short-term and evolutionary game behaviors based on uncertain utility (Q2692120) (← links)
- Information sharing and coordination in a vaccine supply chain (Q6066993) (← links)
- Where to locate <scp>COVID</scp>‐19 mass vaccination facilities? (Q6077337) (← links)
- Optimizing vaccine distribution in developing countries under natural disaster risk (Q6150232) (← links)
- Fair-split distribution of multi-dose vaccines with prioritized age groups and dynamic demand: the case study of COVID-19 (Q6168576) (← links)
- A two-stage decision-support approach for improving sustainable last-mile cold chain logistics operations of COVID-19 vaccines (Q6179168) (← links)
- Designing an integrated responsive-green-cold vaccine supply chain network using Internet-of-Things: artificial intelligence-based solutions (Q6179185) (← links)
- Capacity shortages, regulation, and firm incentives in the generic drugs industry (Q6179279) (← links)
